Peter Ulrich,Katja Baer,Georges Imbert,Marie-Jose Hoellinger,Marie-Emmanuelle Riviere,Ana Graf
申请号：
US13578017
公开号：
US20130011431A1
申请日:
2011.03.28
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to compositions comprising a construct comprising the Aβ1-6 peptide and a pharmaceutically acceptable adjuvant, for the treatment of patients suffering from dementia, in particular dementia of the Alzheimer's type. In one embodiment, the construct containing the Aβ1-6 peptide consists of a virus-like particle (VLP) of the RNA bacteriophage Qβ chemically coupled to said Aβ1-6 peptide.
